Exclusive

Publication

Byline

US Patent Issued to The Broad Institute, Massachusetts Institute of Technology, President and Fellows of Harvard College, Rutgers, the State University of New Jersey, Skolkovo Institute of Science and Technology, The United States of America, as represented by the Secretary, Department of Health and Human Services on July 21 for "CRISPR enzymes and systems" (American, Russian Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,862, issued on July 21, was assigned to The Broad Institute Inc. (Cambridge, Mass.), Massachusetts Institute of Technology (Cambridge, Mass.... Read More


US Patent Issued to Twist Bioscience on July 21 for "Methods and compositions for rapid nucleic library preparation" (California Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,863, issued on July 21, was assigned to Twist Bioscience Corp. (South San Francisco, Calif.). "Methods and compositions for rapid nucleic l... Read More


US Patent Issued to The Regents of the University of California on July 21 for "Methods of producing nucleic acid libraries and compositions and kits for practicing same" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,864, issued on July 21, was assigned to The Regents of the University of California (Oakland, Calif.). "Methods of producing nucleic acid l... Read More


US Patent Issued to Caribou Biosciences on July 21 for "Compositions and methods of nucleic acid-targeting nucleic acids" (California, Maryland Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,865, issued on July 21, was assigned to Caribou Biosciences Inc. (Berkeley, Calif.). "Compositions and methods of nucleic acid-targeting nu... Read More


US Patent Issued to CAMBRIDGE ENTERPRISE on July 21 for "Methods of treating cancer by suppression of FAMIN expression" (British Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,866, issued on July 21, was assigned to CAMBRIDGE ENTERPRISE Ltd. (Cambridge, Great Britain). "Methods of treating cancer by suppression of... Read More


US Patent Issued to OliX Pharmaceuticals on July 21 for "RNAi agent targeting MYD88 and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,867, issued on July 21, was assigned to OliX Pharmaceuticals Inc. (Suwon-si, South Korea). "RNAi agent targeting MYD88 and use thereof" was... Read More


US Patent Issued to University of Rochester on July 21 for "Methods and compositions for rejuvenating CNS glial populations by suppresion of transcription factors" (New York Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,868, issued on July 21, was assigned to University of Rochester (Rochester, N.Y.). "Methods and compositions for rejuvenating CNS glial pop... Read More


US Patent Issued to Amber Bio on July 21 for "Methods and compositions for trans-splicing utilizing trifunctional elements" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,869, issued on July 21, was assigned to Amber Bio Inc. (South San Francisco, Calif.). "Methods and compositions for trans-splicing utilizin... Read More


US Patent Issued to SBI Biotech on July 21 for "TLR9 agonists" (Japanese Inventor)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,870, issued on July 21, was assigned to SBI Biotech Co. Ltd. (Tokyo). "TLR9 agonists" was invented by Eiji Esashi (Tokyo). According to th... Read More


US Patent Issued to Telesis Bio on July 21 for "Genetically engineered Vibrio sp. and uses thereof" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,871, issued on July 21, was assigned to Telesis Bio Inc (San Diego). "Genetically engineered Vibrio sp. and uses thereof" was invented by M... Read More